Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors

NCT02197897 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Tamoxifen Citrate

Sponsor

Baylor College of Medicine

Collaborators

[object Object]